Registry of Sarcoidosis Associated Pulmonary Hypertension (RESAPH)

Conditions:High Blood Pressure (Hypertension), Endocrine
Therapuetic Areas:Cardiology / Vascular Diseases, Endocrinology
Age Range:18 - 100
Start Date:November 2011
End Date:January 2018
Contact:Robert P Baughman, MD

Use our guide to learn which trials are right for you!

Registry to follow patients with sarcoidosis associated pulmonary hypertension

This is a multi center registry of sarcoidosis associated pulmonary hypertension (SAPH).
With this registry, the investigators will characterize the demographics, clinical course,
hemodynamics, pulmonary physiology, and disease management of sarcoidosis associated
pulmonary hypertension on the United States. The investigators will also compare these
features to non-US sites.

Inclusion Criteria:

- Patients with sarcoidosis as defined by the ATS/WASOG statement

- Patients with pulmonary hypertension as confirmed by right heart catheterization

- Patients willing to provide written informed consent

Exclusion Criteria:

- Unwillingness to provide assurance that they will complete the follow up visits for
the study
We found this trial at
2600 Clifton Ave
Cincinnati, Ohio 45267
(513) 556-6000
Principal Investigator: Robert P Baughman, MD
Phone: 513-584-6252
University of Cincinnati The University of Cincinnati offers students a balance of educational excellence and...
Cincinnati, OH
Click here to add this to my saved trials